Neptune Wellness Solutions Stock Forecast, Price & News

Neptune Wellness Solutions' stock was trading at $1.21 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, NEPT shares have increased by 59.5% and is now trading at $1.93.
View which stocks have been most impacted by COVID-19.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Neptune Wellness Solutions in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Neptune Wellness Solutions.

Neptune Wellness Solutions is scheduled to release its next quarterly earnings announcement on Monday, November 9th 2020.
View our earnings forecast for Neptune Wellness Solutions.

Neptune Wellness Solutions Inc (NASDAQ:NEPT) issued its quarterly earnings data on Tuesday, August, 11th. The biotechnology company reported ($0.09) earnings per share for the quarter, missing the consensus estimate of ($0.05) by $0.04. The biotechnology company earned $15.41 million during the quarter, compared to analyst estimates of $15.50 million. Neptune Wellness Solutions had a negative net margin of 142.42% and a negative return on equity of 47.06%.
View Neptune Wellness Solutions' earnings history.

Neptune Wellness Solutions issued an update on its second quarter 2021 After-Hours earnings guidance on Tuesday, August, 11th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $28-32 million.

3 analysts have issued twelve-month price objectives for Neptune Wellness Solutions' stock. Their forecasts range from $3.75 to $6.00. On average, they anticipate Neptune Wellness Solutions' share price to reach $4.88 in the next twelve months. This suggests a possible upside of 152.6% from the stock's current price.
View analysts' price targets for Neptune Wellness Solutions.

Neptune Wellness Solutions saw a decline in short interest in the month of September. As of September 15th, there was short interest totaling 7,840,000 shares, a decline of 9.2% from the August 31st total of 8,630,000 shares. Based on an average daily volume of 682,200 shares, the short-interest ratio is currently 11.5 days. Currently, 8.2% of the company's stock are sold short.
View Neptune Wellness Solutions' Short Interest.

Some companies that are related to Neptune Wellness Solutions include Repare Therapeutics (RPTX), ImmunoGen (IMGN), Nabriva Therapeutics (NBRV), Supernus Pharmaceuticals (SUPN), Nkarta (NKTX), Rhythm Pharmaceuticals (RYTM), Amphastar Pharmaceuticals (AMPH), Athenex (ATNX), Intercept Pharmaceuticals (ICPT), Akero Therapeutics (AKRO), Northwest Biotherapeutics (NWBO), Enanta Pharmaceuticals (ENTA), Tocagen (TOCA), Esperion Therapeutics (ESPR) and Arvinas (ARVN).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Neptune Wellness Solutions investors own include Canopy Growth (CGC), Tilray (TLRY), Aurora Cannabis (ACB), Cronos Group (CRON), Aphria (APHA), Cara Therapeutics (CARA), Innovative Industrial Properties (IIPR), Zynerba Pharmaceuticals (ZYNE), Amarin (AMRN) and New Age Beverages (NBEV).

Neptune Wellness Solutions trades on the NASDAQ under the ticker symbol "NEPT."

Neptune Wellness Solutions' stock is owned by a number of institutional and retail investors. Top institutional shareholders include Toronto Dominion Bank (0.01%).

NEPT stock was purchased by a variety of institutional investors in the last quarter, including Toronto Dominion Bank.

Shares of NEPT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of NEPT stock can currently be purchased for approximately $1.93.

Neptune Wellness Solutions has a market capitalization of $248.51 million and generates $22.05 million in revenue each year. The biotechnology company earns $-45,760,000.00 in net income (profit) each year or ($0.43) on an earnings per share basis. Neptune Wellness Solutions employs 58 workers across the globe.

The official website for Neptune Wellness Solutions is www.neptunecorp.com.

Neptune Wellness Solutions' mailing address is 545 PROMENADE DU CENTROPOLIS SUITE 100, LAVAL A8, H7T 0A3. The biotechnology company can be reached via phone at 45-0687-2262 or via email at [email protected]